| Literature DB >> 28639075 |
Sarah Woltz1, Alysia Sengab2, Pieta Krijnen2, Inger B Schipper2.
Abstract
INTRODUCTION: Clavicular shortening due to non-anatomical healing of displaced clavicular fractures is believed to have a negative effect on shoulder function after recovery. The evidence for this, however, is equivocal. This review aimed to systematically evaluate the available literature to determine whether the current beliefs about clavicular shortening can be substantiated.Entities:
Keywords: Clavicular shortening; Malunion; Nonoperative treatment; Shoulder function
Mesh:
Year: 2017 PMID: 28639075 PMCID: PMC5511301 DOI: 10.1007/s00402-017-2734-7
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 3.067
Fig. 1Flowchart of the included articles
Characteristics of the included studies and patients analyzed
| References | Study design | No. of evaluated patientsa | Mean time since trauma, months | Mean age, years (SD) | Male (%) | Type of nonoperative treatment |
|---|---|---|---|---|---|---|
| Fuglesang et al. [ | Retrospective | 59/92 | 32 (12–59) | 39.1 (12.3) | 83 | Sling |
| Figueiredo et al. [ | Prospective | 54/59 | 12 | 34 (13) | 81 | FEB + PT |
| Stegeman et al. [ | Retrospective | 32/74 | 12–72 | Median 31 (range 21–62) | 84 | Not reported |
| Rasmussen et al. [ | Retrospective | 136/237 | 55 (24–83) | 35 (15) | 79 | FEB ( |
| Postacchini et al. [ | Retrospective | 68/119b | 104 | 36.9 | 65 | Sling or FEB |
| McKee et al. [ | Retrospective | 30/63 | 55 (12–72) | 37 | 73 | Sling |
SD standard deviation, FEB figure of eight bandage, C&C collar and cuff, PT physiotherapy
aNo of evaluated patients/no of eligible patients (or included patients for prospective study)
b119 patients were eligible for inclusion in total. Number of eligible patients with Allman type 1b/c fracture not stated
Relation between clavicular shortening and Constant score and/or DASH score
| References | Mean shortening in mm (SD) | Mean Constant score (SD) | Mean DASH score (SD) | Correlation ( |
|---|---|---|---|---|
| Fuglesang et al. [ | 17.1 (7.1) | 81 (69–90) (median) | 6.7 (0.8–19) (median) | |
| <15 mm: | 80 (64–88) | 7 (3–27) |
| |
| >15 mm: | 84 (74–90) | 7 (0–11) |
| |
| Figueiredo et al. [ | 9.2 (6.4) | N/A | 3.38 (9.21) |
|
| <20 mm: | 3.38 (CI 9.56) |
| ||
| >20 mm: | 3.33 (CI 7.02) | |||
| Rasmussen et al. [ | 11.6 (8.2) | 86.3 (29–100) | N/A |
|
| <20: | 7.2 (10.3)a |
| ||
| >20: | 7.9 (10.3) | |||
| Postacchini et al. [ | Males: 14.1 (8.9); | Allman 1Bc: 87.1 | N/A | |
| Females: 10.9 (7.8); 8.3% (6.0%)1 | CS ≥ 90 ( |
| ||
| McKee et al. [ | 14.5 (8.6) | 71 (SD not given) | 24.6 (SD not given) |
|
| <20 mm: |
| |||
| ≥20 mm: | DASH > 30 points: |
aMean difference in Constant score between injured and uninjured shoulder
bProportional shortening: overlap of fracture fragments divided by sum of overlap and length of injured clavicle
cAllman type 1B: displaced fractures, Allman type 1C: displaced with third bone fragment
Relation between clavicular shortening and shoulder strength
| References | Mean shortening in mm (SD) | Mean strength in Newton (95% CI) | Correlation or |
|---|---|---|---|
| Stegeman et al. [ | 25 (16) | Adduction: 7.2 (−3.5 to 18)b |
|
| 13% (8%)a | Abduction: −0.1 (−8.8 to 8.6) |
| |
| Anteflexion: 9.6 (−3.1 to 22) |
| ||
| Retroflexion: 14.6 (−6.7 to 9.8) |
| ||
| Exorotation: 2.0 (−3.2 to 7.3) |
| ||
| Endorotation: 5.1 (−0.8 to 11.1) |
| ||
| McKee et al. [ | 14.5 (8.6 | Flexion: 81%, 75%c | ns |
| Abduction: 82%, 67% |
| ||
| <20: | Exorotation: 81%, 82% | ns | |
| ≥20: | Endorotation: 85%, 78% | ns |
aProportional shortening: overlap of fracture fragments divided by sum of overlap and length of injured clavicle
bDifference in strength between uninjured and injured shoulder. p > 0.05 for all comparisons
cStrength and endurance of injured shoulder as a percentage of the uninjured shoulder
Methodological quality of included studies assessed according to the Methodological Index for Non-Randomized Studies (MINORS) instrument [20]
| Fugle-sang et al. [ | Figueiredo et al. [ | Stege-man et al. [ | Rasmussen et al. [ | Postac-chini et al. [ | McKee et al. [ | |
|---|---|---|---|---|---|---|
| 1. A clearly stated aim | 2 | 2 | 2 | 2 | 2 | 2 |
| 2. Inclusion of consecutive patients | 1 | 2 | 1 | 1 | 1 | 1 |
| 3. Prospective collection of dataa | 2 | 2 | 2 | 2 | 2 | 2 |
| 4. Endpoints appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 | 2 |
| 5. Unbiased assessment of the study endpoint | 0 | 0 | 0 | 0 | 1 | 1 |
| 6. Follow-up period appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 | 2 |
| 7. Loss to follow-up less than 5% | 2 | 1 | 2 | 2 | 2 | 2 |
| 8. Prospective calculation of the study size | 0 | 0 | 1 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 11 | 12 | 12 |
The items are scored 0 (not reported), 1 (reported but inadequate) or 2 (reported and adequate). Maximum score is 16
aData were collected according to a protocol established before the beginning of the study